P. V. G. K Sarma | Biochemistry | Editorial Board Member

Assoc. Prof. Dr. P. V. G. K Sarma | Biochemistry | Editorial Board Member 

Associate Professor | Sri Venkateswara Institute of Medical Sciences | India

P. V. G. K. Sarma is a senior Indian biotechnologist and academic leader currently serving as the Head of the Department of Biotechnology at the Sri Venkateswara Institute of Medical Sciences, Tirupati, a position he has held since 2004, with his academic training from JNTU Hyderabad and a broad research portfolio reflected in over a hundred scholarly publications indexed across major journals. P. V. G. K. Sarma His core research spans genetic engineering, microbial biotechnology, functional genomics, structural bioinformatics, and stem cell differentiation with a strong translational focus on regenerative medicine and human disease. A major strength of his work lies in the in vitro differentiation of human CD34+ hematopoietic stem cells into diverse lineages including pancreatic β-cells, erythrocytes, podocytes, type-II pneumocytes, keratinocytes, chondrocytes, and megakaryocytes, contributing to the understanding of cellular plasticity and therapeutic cell generation. Parallel to this, he has made significant contributions to microbial pathogenesis, particularly on Staphylococcus aureus, elucidating molecular mechanisms of biofilm formation, metabolic regulation, and antimicrobial resistance, including MRSA, through gene expression, enzyme activity, and structure-based drug design approaches. His interdisciplinary research also addresses clinical and molecular genetics, with notable studies on mutations linked to congenital erythrocytosis, breast cancer, leukemia drug resistance, rheumatoid arthritis, tuberculosis susceptibility, cardiovascular disease, and pain genetics. During the COVID-19 period, his in silico investigations on antiviral compounds targeting SARS-CoV-2 proteins further demonstrated his adaptability across emerging biomedical challenges. He has consistently integrated wet-lab experimentation with computational biology, signaling pathways, and nanobiotechnology, including cytotoxicity studies of silver nanoparticles on human stem cells. Beyond research, he is actively involved in peer review for reputed international journals and contributes to clinical translational science through collaborations across medicine, genetics, and biotechnology. Collectively, his career reflects sustained leadership in Indian biomedical research, with impactful contributions to stem cell biology, microbial biotechnology, and molecular genetics aimed at advancing diagnostics, therapeutics, and regenerative strategies.

Profile: ORCID

Featured Publications

  1. Chandrasekhar, C., Kumar, P. S., & Sarma, P. V. G. K. (2019). Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients. Scientific Reports, 9, 38672.

  2. Loganathan, S. E., Kattaru, S., Kodavala, S., Chandrasekhar, C., & Sarma, P. V. G. K. (2024). Prominent expression of COL2A1, ACAN and IHH genes observed in the differentiation of human hematopoietic stem cells into articular type of chondrocytes. Stem Cell Reviews and Reports, 20.

  3. Kodavala, S., Loganathan, S. E., Kattaru, S., Chandrasekhar, C., & Sarma, P. V. G. K. (2024). In vitro generation of epidermal keratinocytes from human CD34-positive hematopoietic stem cells. In Vitro Cellular & Developmental Biology – Animal, 60.

  4. Suthi, S., Mounika, A., & Sarma, P. V. G. K. (2023). Elevated acetate kinase (ackA) gene expression, activity, and biofilm formation observed in methicillin-resistant strains of Staphylococcus aureus. Journal of Genetic Engineering and Biotechnology, 21.

  5. Kattaru, S., Manne Mudhu, S., Loganathan, S. E., Kodavala, S., & Sarma, P. V. G. K. (2021). Increased insulin and GLUT2 gene expression and elevated glucokinase activity in β-like cells of islets of Langerhans differentiated from human haematopoietic stem cells on treatment with Costus igneus leaf extract. Molecular Biology Reports, 48.

P. V. G. K. Sarma has advanced translational biotechnology through pioneering stem cell differentiation, molecular genetics, and microbial pathogenesis research that directly supports regenerative medicine and precision diagnostics. His work bridges laboratory science with clinical and industrial applications, contributing to improved disease understanding, therapeutic development, and global biomedical innovation.

Safa Tahmasebi | Biochemistry | Best Researcher Award | 10070

Dr. Safa Tahmasebi | Biochemistry | Best Researcher Award

PhD of Immunology at Shahid Beheshti University of Medical Sciences | Iran

Dr. Safa Tahmasebi is an accomplished researcher in medical immunology, with expertise in cancer immunotherapy, stem cell biology, exosome research, and immune regulation in infectious and autoimmune diseases. Holding a PhD in Medical Immunology from Shahid Beheshti University of Medical Sciences, she has led and collaborated on numerous impactful projects, including translational research on CAR-T and CAR-NK therapies and novel immunotherapeutic strategies. She has authored multiple publications in high-impact journals indexed in Scopus and PubMed, alongside contributions to books and international congresses where she has delivered invited lectures and top-ranked presentations. Beyond research, she has demonstrated leadership in student research committees, organized academic workshops, and contributed to community platforms. Her achievements reflect strong academic excellence, research innovation, and a commitment to advancing global healthcare through science and education.

Professional Profiles

Google Scholar | Scopus | Orcid

Education

Dr. Safa Tahmasebi has pursued a distinguished academic path in the field of medical sciences, consistently excelling at every stage. She completed her Bachelor’s degree in Laboratory Sciences, achieving first rank throughout her studies. She then earned a Master’s in Medical Immunology, securing top positions in the national entrance examinations, followed by a PhD in Medical Immunology from Shahid Beheshti University of Medical Sciences. During her doctoral studies, she specialized in advanced immunological mechanisms, cancer immunotherapy, and translational medicine, with a strong focus on CAR-T and CAR-NK therapies. Her educational background reflects academic excellence, perseverance, and a deep commitment to scientific advancement. The rigorous training she received has laid a strong foundation for her subsequent professional and research contributions, preparing her to lead innovative projects at both national and international levels.

Experience

Dr. Safa Tahmasebi has gained extensive professional experience as a researcher, educator, and academic leader. She has served as an executive and collaborator in multiple high-impact research projects, including studies on immunotherapy, stem cell applications, exosomes in cancer progression, and immune responses in infectious diseases. Her role extends beyond laboratory research into teaching, where she has conducted theoretical and practical courses in immunology for students in medicine, nursing, pharmacy, and dentistry. She has also organized advanced workshops on systematic reviews, SPSS, ELISA, and cancer immunology, equipping young researchers with essential scientific skills. Additionally, she has been actively involved in student research committees and community platforms, taking leadership roles in guiding scientific initiatives. Through these experiences, she has demonstrated a balance of research innovation, academic mentoring, and community engagement.

Research Interest

Dr. Safa Tahmasebi’s research interests lie at the intersection of immunology, oncology, and translational medicine, with a particular focus on innovative therapeutic strategies. Her primary work involves developing and improving cancer immunotherapies such as CAR-T and CAR-NK cell therapies, investigating tumor microenvironment dynamics, and exploring the roles of exosomes and non-coding RNAs in cancer progression. She is also deeply engaged in studying immune regulation in autoimmune and infectious diseases, including COVID-19, where she has published widely on vaccine responses and immunomodulatory therapies. Her interests extend to anti-aging research, stem cell-based therapies, and the application of artificial intelligence in cancer prediction and treatment. With an emphasis on bridging laboratory research with clinical application, her vision is to advance therapies that significantly improve patient outcomes and contribute to global health solutions.

Awards and Honors

Dr. Safa Tahmasebi has received numerous awards and honors that recognize her academic excellence, research achievements, and community contributions. She has consistently ranked first in national examinations for both her Master’s and PhD programs, highlighting her strong academic foundation. Her achievements include being selected as a model student at both institutional and provincial levels, receiving the National Student Dedication Award for social responsibility, and earning recognition from the National Elite Foundation through multiple Shahid Zazai Projects for top students. She has also been honored as the Outstanding Research Student and selected for the Immunology and Allergy Festival as a leading PhD researcher. These accolades reflect her commitment to scientific excellence, leadership, and service to society, reinforcing her reputation as a highly accomplished and respected young researcher.

Research Skills

Dr. Safa Tahmasebi possesses a comprehensive set of research skills that combine technical expertise with strong analytical and leadership abilities. She is proficient in advanced laboratory techniques such as cell culture, ELISA, flow cytometry, molecular biology methods, and immunological assays. Her expertise extends to systematic reviews, meta-analysis, and the application of statistical tools like SPSS for biomedical research. She has successfully led projects involving experimental models of cancer, immunomodulatory therapies, and exosome-based studies, demonstrating skill in both experimental design and translational application. Additionally, she has significant experience in academic writing, with numerous publications in high-impact journals, books, and conference proceedings. Her ability to lead interdisciplinary projects, collaborate internationally, and mentor students underscores her strengths not only as a researcher but also as an academic leader committed to advancing medical science.

Publication Top Notes

Title: CAR T cells in solid tumors: challenges and opportunities
Year: 2021
Citations: 660

Title: Exosome engineering in cell therapy and drug delivery
Year: 2023
Citations: 250

Title: Recent advances in non-small cell lung cancer targeted therapy; an update review
Year: 2023
Citations: 228

Title: Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
Year: 2021
Citations: 202

Title: Th17 and Treg cells function in SARS‐CoV2 patients compared with healthy controls
Year: 2020
Citations: 184

Title: The effects of oxygen–ozone therapy on regulatory T‐cell responses in multiple sclerosis patients
Year: 2021
Citations: 171

Title: CAR-T cell combination therapy: the next revolution in cancer treatment
Year: 2022
Citations: 135

Title: Solid tumors challenges and new insights of CAR T cell engineering
Year: 2019
Citations: 122

Title: Immune cell hacking: challenges and clinical approaches to create smarter generations of chimeric antigen receptor T cells
Year: 2018
Citations: 93

Title: CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
Year: 2023
Citations: 74

Title: Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2
Year: 2021
Citations: 74

Title: Chimeric antigen receptor-T cell therapy: Applications and challenges in treatment of allergy and asthma
Year: 2020
Citations: 73

Title: Programmable and multi-targeted CARs: a new breakthrough in cancer CAR-T cell therapy
Year: 2020
Citations: 61

Title: The outlook for diagnostic purposes of the 2019‐novel coronavirus disease
Year: 2020
Citations: 49

Title: Study of immunomodulatory effects of mesenchymal stem cell-derived exosomes in a mouse model of LPS induced systemic inflammation
Year: 2022
Citations: 41

Title: Pro-tumorigenic and Anti-tumorigenic Roles of Pro-inflammatory Cytokines in Cancer
Year: 2022
Citations: 40

Title: Changes in Th17 cells frequency and function after ozone therapy used to treat multiple sclerosis patients
Year: 2020
Citations: 39

Title: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism
Year: 2021
Citations: 38

Title: Mesenchymal stem cell-based therapy as a new therapeutic approach for acute inflammation
Year: 2023
Citations: 34

Title: Longevity and anti-aging effects of curcumin supplementation
Year: 2024
Citations: 33

Title: Recent advances in antibody‐based immunotherapy strategies for COVID‐19
Year: 2021
Citations: 33

Title: E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy
Year: 2021
Citations: 32

Title: IL-38 as an early predictor of the ischemic stroke prognosis
Year: 2021
Citations: 30

Title: Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2
Year: 2021
Citations: 30

Title: Immune-based therapy for COVID-19
Year: 2021
Citations: 26

Title: Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?
Year: 2024
Citations: 20

Title: Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function
Year: 2022
Citations: 16

Title: Epigenetic biomarkers in aging and longevity: Current and future application
Year: 2024
Citations: 15

Title: Cellular and biological factors involved in healing wounds and burns and treatment options in tissue engineering
Year: 2022
Citations: 15

Title: Handbook of cancer and immunology
Year: 2022
Citations: 15

Title: Artificial intelligence for prediction of metastasis risk and survival
Year: 2024
Citations: 11

Title: The effects of methotrexate on the immune responses to the COVID-19 vaccines in the patients with immune-mediated inflammatory disease
Year: 2023
Citations: 10

Title: CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies
Year: 2023
Citations: 9

Title: COVID-19: our current knowledge of epidemiology, pathology, therapeutic approaches, and diagnostic methods
Year: 2021
Citations: 9

Title: Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies
Year: 2025
Citations: 7

Title: Immunogenicity of COVID‐19 vaccines in adult patients with autoimmune inflammatory rheumatic diseases: a systematic review and meta‐analysis
Year: 2023
Citations: 7

Title: Recent innovative approaches to intensify the efficacy and safety of CAR-T cell therapy in cancers
Year: 2022
Citations: 6

Title: Glycolysis and Autoimmune Diseases: A Growing Relationship
Year: 2020
Citations: 6

Title: Harnessing immunotherapy for hepatocellular carcinoma: Principles and emerging promises
Year: 2025
Citations: 5

Title: Effect of genetic profiling on surgical decisions at hereditary colorectal cancer syndromes
Year: 2024
Citations: 5

Title: The effects of guluronic acid (G2013), a new emerging treatment, on inflammatory factors in nonalcoholic steatohepatitis patients under in vitro conditions
Year: 2021
Citations: 3

Title: Harnessing the fundamental roles of vitamins: the potent anti-oxidants in longevity
Year: 2025
Citations: 2

Title: Peptides in breast cancer therapy: From mechanisms to emerging drug delivery and immunotherapy strategies
Year: 2025
Citations: 2

Title: Harnessing IL-27: challenges and potential in cancer immunotherapy
Year: 2025
Citations: 2

Title: Anti-aging natural supplements: the main players in promoting healthy lifespan
Year: 2024
Citations: 2

Title: The Assessment of Anti–SARS‐CoV‐2 Antibodies in Different Vaccine Platforms
Year: 2024
Citations: 2

Title: Immunity to tetanus vaccination in pregnant women in Zanjan province, northwest of Iran
Year: 2018
Citations: 2

Title: Applications of CRISPR-Cas9 in mitigating cellular senescence and age-related disease progression
Year: 2025
Citation: 1

Title: CCAT2 role in gastrointestinal cancer progression and metastasis
Year: 2025
Citation: 1

Title: Breaking barriers: CAR-NK cell therapy breakthroughs in female-related cancers
Year: 2025
Citation: 1

Title: DCLK1 in gastrointestinal cancer: A driver of tumor progression and a promising therapeutic target
Year: 2025
Citation: 1

Title: Macrophage polarization in hepatocellular carcinoma: a lncRNA-centric perspective on tumor progression and metastasis
Year: 2025
Citation: 1

Title: Translating preclinical insights into clinical strategies: Targeting cancer stem cells and stemness in prostate cancer
Year: 2025
Citation: 1

Conclusion

In conclusion, Dr. Safa Tahmasebi represents an exceptional example of academic excellence, research innovation, and leadership in the field of medical immunology. With a strong educational foundation, extensive professional experience, and impactful research contributions in cancer immunotherapy, stem cell biology, and immune regulation, she has established herself as a promising scientist. Her awards and honors further demonstrate her commitment to excellence, while her diverse research skills highlight her ability to bridge theory and practice. Through her publications, lectures, and community involvement, she has already made significant contributions to science and society. With her vision for advancing immunological therapies and her ability to inspire and mentor others, she holds immense potential to continue making groundbreaking contributions and is highly deserving of recognition through prestigious research awards.

Dmitry Baytin | Biochemistry | Best Researcher Award

Dr. Dmitry Baytin | Biochemistry | Best Researcher Award

Senior Scientist at Peter the Great St. Petersburg Polytechnic University, Russia

Dr. Dmitry Baytin is a distinguished research scientist specializing in protein biochemistry, with a focus on RecA and SOS response proteins from various bacterial species. He holds a Ph.D. in biochemistry and a Doctor of Sciences degree, complemented by postdoctoral training in leading international laboratories. His expertise lies in DNA repair mechanisms, homologous recombination, and the molecular basis of antibiotic resistance, where he has made notable contributions through the development of innovative models and inhibitors targeting RecA activity. Dr. Baytin has authored more than 25 publications in high-impact journals, secured competitive research grants, and contributed to patented innovations. Currently serving as a senior researcher, he collaborates internationally, mentors young scientists, and advances fundamental discoveries with significant implications for combating antibiotic resistance and enhancing molecular biology research.

Professional Profile

Somashekara Rajashekara | Molecular Biology | Best Researcher Award

Dr. Somashekara Rajashekara | Molecular Biology | Best Researcher Award

Assistant Professor (Temporary) at Bangalore University, India

Dr. Somashekara Rajashekara is an accomplished ornithologist and biodiversity researcher with extensive teaching and research experience. His academic journey spans over two decades, with contributions to higher education and wildlife conservation. His expertise in avian biodiversity and ecological monitoring has played a vital role in conservation efforts. Through his research and mentorship, he continues to shape the next generation of zoologists and conservationists.

Publication Profile

scopus

scholar

orcid

Educational Details

Dr. Somashekara Rajashekara holds a Ph.D. in Zoology from Bangalore University (2012), specializing in Ornithology with a focus on biodiversity, bio-ecology, and conservation. He earned an M.Phil. in Zoology from Periyar University (2006), where he studied research methodology, ornithology, and wildlife biology. His M.Sc. in Zoology from Bangalore University (2002) covered comparative and applied zoology, genetics, environmental biology, and related subjects. He completed his B.Sc. in Botany, Chemistry, and Zoology from Bangalore University (2000) and secured his S.S.L.C. from KSEEB, Karnataka (1995). Additionally, he cleared the Karnataka State Eligibility Test (KSET) in Life Sciences (2015) and pursued specialized training in bioinformatics at Peking University, China, and genetics education at the American Museum of Natural History, USA.

Professional Experience

With over a decade of experience in higher education and research, Dr. Rajashekara has served as a Guest Faculty at Bangalore University’s Centre for Applied Genetics since 2013, teaching M.Sc. students. He also taught integrated B.Sc.-M.Sc. students at the School of Natural Science from 2012 to 2016. His prior roles include teaching positions at the Department of Zoology, Bangalore University, and Government Science College, Bengaluru. As a research scholar, he contributed to multiple projects, including serving as a Research Field Assistant for a DST Project (WOS-B Scheme). He has been actively involved in mentoring postgraduate students and conducting research on avian biodiversity and ecosystem conservation.

Research Interest

Dr. Rajashekara’s research focuses on ornithology, bird biodiversity and conservation, bio-ecology, wildlife biology, environmental monitoring, and applied zoology. His work contributes to understanding avian ecology and developing conservation strategies for sustaining biodiversity.

Top Noted Publication

  • “Collagen as the Extracellular Matrix Biomaterials in the Arena of Medical Sciences”

    • Authors: R. Sowbhagya, H. Muktha, T.N. Ramakrishnaiah, K. Roopini, S. Rajashekara
    • Journal: Tissue and Cell, 2024
    • Citations: 5
    • Access: Open access

    Summary: This comprehensive review delves into the pivotal role of collagen as an extracellular matrix (ECM) biomaterial in medical applications. It emphasizes collagen’s structural and functional significance in tissue engineering and regenerative medicine. The article explores collagen’s applications in bone regeneration, wound healing, cardiovascular tissue engineering, and dentistry.

  • “CRISPR/Cas-Mediated Genome Editing in Mice for the Development of Drug Delivery Mechanisms”

    • Authors: R. Sowbhagya, H. Muktha, T.N. Ramakrishnaiah, K. Nivitha, S. Rajashekara
    • Journal: Molecular Biology Reports, 2023
    • Citations: Data not specified
    • Access: Information not specified

    Summary: This review focuses on the utilization of CRISPR/Cas9 genome editing technology in mice to develop advanced drug delivery systems. It discusses the creation of precise animal models for human diseases, facilitating the study of therapeutic interventions and the optimization of drug delivery mechanisms.

Conclusion

Dr. Somashekara Rajashekara’s multidisciplinary expertise, research contributions, and academic leadership make him a strong candidate for the Best Researcher Award. His work bridges molecular biology, ornithology, genetics, and conservation, contributing significantly to scientific advancements. Further efforts in expanding collaborations, securing research funding, and increasing citations will enhance his profile as a leading researcher in his field.

Biochemistry

Introduction of Biochemistry:

Biochemistry is a fascinating and multidisciplinary branch of science that delves into the intricate molecular processes governing life. It investigates the chemical reactions and interactions within biological systems, uncovering the molecular basis of various physiological and pathological phenomena.

Protein Structure and Function:

This subfield explores the three-dimensional structures of proteins and their functions in cellular processes. Understanding protein structure is vital for drug design, molecular biology, and disease research.

Molecular Genetics:

Molecular genetics investigates the molecular mechanisms underlying inheritance, gene expression, and regulation. Researchers in this area study DNA, RNA, and the proteins that control genetic information.

Metabolic Pathways and Bioenergetics:

Biochemists examine the intricate metabolic pathways that regulate energy production, storage, and utilization within cells. This research is essential for understanding diseases like diabetes and obesity.

Proteomics and Functional Genomics:

Proteomics involves the large-scale study of proteins, while functional genomics focuses on understanding gene function on a genome-wide scale. These fields aid in uncovering the roles of genes and proteins in various biological processes.